Enhabit, Inc. (NYSE:EHAB) Receives Consensus Rating of “Hold” from Brokerages

Shares of Enhabit, Inc. (NYSE:EHAB) have earned an average rating of “Hold” from the six ratings firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $8.75.

A number of research analysts have recently issued reports on the stock. Leerink Partners reiterated a “market perform” rating and set a $8.00 price target (down from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. Jefferies Financial Group raised Enhabit from a “hold” rating to a “buy” rating and upped their price objective for the stock from $8.25 to $9.50 in a report on Monday, December 9th.

Insider Activity at Enhabit

In related news, Director Jeffrey Bolton acquired 4,000 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The stock was purchased at an average cost of $8.69 per share, for a total transaction of $34,760.00. Following the transaction, the director now directly owns 98,144 shares of the company’s stock, valued at approximately $852,871.36. This trade represents a 4.25 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Stuart M. Mcguigan bought 15,000 shares of the stock in a transaction on Tuesday, December 10th. The shares were bought at an average price of $8.81 per share, for a total transaction of $132,150.00. Following the acquisition, the director now owns 46,810 shares in the company, valued at $412,396.10. The trade was a 47.15 % increase in their position. The disclosure for this purchase can be found here. 1.90% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. WINTON GROUP Ltd purchased a new stake in shares of Enhabit during the second quarter worth about $955,000. Marshall Wace LLP acquired a new stake in Enhabit during the second quarter worth approximately $1,941,000. Systematic Financial Management LP grew its stake in Enhabit by 12.2% in the 3rd quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock worth $14,522,000 after acquiring an additional 199,235 shares during the period. Dynamic Technology Lab Private Ltd acquired a new position in Enhabit in the 3rd quarter valued at $215,000. Finally, AREX Capital Management LP lifted its stake in shares of Enhabit by 2.5% during the 2nd quarter. AREX Capital Management LP now owns 2,472,662 shares of the company’s stock worth $22,056,000 after purchasing an additional 59,353 shares during the period.

Enhabit Price Performance

Shares of EHAB opened at $7.93 on Friday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. Enhabit has a fifty-two week low of $6.85 and a fifty-two week high of $11.74. The firm has a 50-day simple moving average of $7.60 and a 200-day simple moving average of $8.29. The company has a market capitalization of $398.75 million, a price-to-earnings ratio of -3.42 and a beta of 1.89.

Enhabit (NYSE:EHAB) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The company had revenue of $253.60 million for the quarter, compared to analyst estimates of $261.69 million. During the same period in the previous year, the business posted $0.03 earnings per share. On average, equities research analysts anticipate that Enhabit will post 0.22 earnings per share for the current year.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.